Artificial Intelligence in Oncology Market Report 2025, Trends, Growth drivers, Opportunities and Competitive Landscape in 2032 | Azra AI, IBM Corporation, Siemens Healthineers AG, Intel Corporation
The Global Artificial Intelligence in Oncology Market is projected to reach USD 16,382.0 Mn by 2032. This growth represents a significant compound annual growth rate of 33.7% from 2025 to 2032. The estimated value for 2025 is USD 2,145.1 Mn. The increasing adoption of AI technologies in oncology is driving this market growth. This sector holds promise for advancing cancer diagnosis and treatment through innovative AI applications.
Artificial Intelligence in Oncology Market Report 2025, Trends, Growth drivers, Opportunities and Competitive Landscape in 2032 | Azra AI, IBM Corporation, Siemens Healthineers AG, Intel Corporation 04-08-2025 09:09 AM CET | Health & Medicine
Press release from: Coherent Market Insights
Global Artificial Intelligence in Oncology Market is estimated to be valued at USD 2,145.1 Mn in 2025 and is expected to reach USD 16,382.0 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 33.7% from 2025 to 2032. Latest Qualitative Research Report on the Global Artificial Intelligence in Oncology Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032.
The comprehensive research explores into the evolving Market's dynamics, value chain analysis, prominent investment areas, competitive landscape, drivers and constraints, regional outlook, and key market segments. It also provides the industry overview with growth analysis and historical & futuristic cost, Statistics, revenue, demand and supply data (as applicable).
Additionally, the report highlights effective strategies and opportunities within the market, providing essential guidance for industry professionals, policymakers, stakeholders, investors, and newcomers. This will help them identify key strategies, explore market size opportunities, and gain a competitive advantage in the Global Artificial Intelligence in Oncology Market.
Main Aim of the Report
The primary aim of the report is to provide readers with a comprehensive analysis of the market, enabling them to develop effective business growth strategies, evaluate the competitive landscape, assess their current market position, and make informed business decisions related to the Global Artificial Intelligence in Oncology Market. The report offers key projections on critical factors such as market size, production, revenue, consumption, CAGR, gross margin, and pricing. It is based on the most reliable primary and secondary research methods and resources available.
Market Scope
A key focus of the report is the comprehensive segmentation of the Global Artificial Intelligence in Oncology Market, which includes product types, applications, end-user markets, major geographic regions, and leading market competitors. The report offers unbiased expert insights into the current market conditions, past performance, production and consumption trends, supply and demand ratios, and revenue forecasts for the projected period.
The financial standings of key players, including gross profits, sales volumes, revenue, manufacturing costs, and other financial ratios, are accurately assessed. Additionally, analytical tools such as investment evaluation, SWOT analysis, and Porter's Five Forces analysis have been employed to examine the production and distribution capabilities of market participants.
Players Analyzed
The report also features a dedicated section on major players, where our analysts provide an in-depth review of their financial statements, product benchmarking, and SWOT analysis. The competitive landscape section further covers key development strategies, market share, and ranking analysis of these players globally. Players analyzed in the report include Azra AI, IBM Corporation, Siemens Healthineers AG, Intel Corporation, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., ConcertAI, Median Technologies, PathAI, Microsoft, Zebra Medical Vision, and Babylon.
Detailed Segmentation and Classification
The report includes detailed segmentation by component, cancer type, treatment type, and end user. Here are some key segments:
- By Component: Software/Platform, Hardware, Services
- By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others
- By Treatment Type: Chemotherapy, Radiotherapy, Immunotherapy, Others
- By End User: Hospitals & Clinics, Diagnostic Centers, Biopharmaceutical Companies, Others
Regional Analysis
The Report provides deep-dive qualitative and quantitative analysis on Global Artificial Intelligence in Oncology Market for all the regions and countries covered below:
- North America (the United States, Canada, and Mexico)
- Europe (Germany, France, Italy, United Kingdom, SCANDIVAN, Benelux, Russia, and Rest of Europe)
- Asia-Pacific (Japan, South Korea, India, China, Southeast Asia, and Australia)
- South America (Brazil, Argentina, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa, and Rest of the Middle East & Africa)
Highlights of Our Report
The report provides extensive market analysis, corporate insights, consumption trends, segmentation details, pricing evaluation, and future outlook. It offers valuable information, competitive intelligence, helps in making informed investment decisions, and staying up-to-date on industry developments.
About the Author
Author of this marketing PR: Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting clients achieve transformational growth by helping them make critical business decisions. They are committed to offering insights in various sectors post-COVID-19 and delivering measurable, sustainable results for clients.
Contact Us:
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
United States of America: +12524771362
United Kingdom: UK Number: +442039578553
Australia: +61-2-4786-0457
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com